IP Library › Granted Patent US 11,654,214
Granted Patent B2
US 11,654,214 · App. 15/963,348 · Granted May 23, 2023

Ceramic-containing bioactive inks and printing methods for tissue engineering applications

Inventors: Ramille N. Shah (Oak Brook, IL); Adam E. Jakus (Chicago, IL)
Assignee: NORTHWESTERN UNIVERSITY
A61L27/56A61L27/46A61L27/54A61L27/58B33Y70/10C09D11/037C09D11/104C09D11/322C09D167/04A61L2300/442A61L2430/02A61L2430/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,654,214
App. No.
15/963,348
Granted
May 23, 2023
Kind
B2
Abstract

Ink formulations comprising bioactive particles, methods of printing the inks into three-dimensional (3D) structures, and methods of making the inks are provided. Also provided are objects, such as tissue growth scaffolds and artificial bone, made from the inks, methods of forming the objects using 3D printing techniques, and method for growing tissue on the tissue growth scaffolds. The inks comprise a plurality of bioactive ceramic particles, a biocompatible polymer binder, optionally at least one bioactive factor, and a solvent.

Claims (33)

1. A solvent-based 3D printed porous tissue growth material comprising at least one layer formed from a solvent-based ink extruded at room temperature with the solvent evaporated upon extruding, the at least one layer comprises one or more porous fibers, a microstructure of the one or more porous fibers is a continuous matrix of a biocompatible polymer binder with intra fiber pores and bioactive ceramic particles dispersed throughout the microstructure, the bioactive ceramic particles make up at least 70 weight percent of the one or more porous fibers, and the one or more porous fibers are osteogenically active and can undergo a reversible deformation when a compressive or tensile stress is applied and then removed.

2. The material of claim 1 comprising a plurality of stacked layers, each layer in the plurality of stacked layers comprising one or more of the porous fibers.

3. The materials of claim 1 comprising a plurality of the porous fibers.

4. The material of claim 1 , wherein the bioactive ceramic particles make up at least 90 weight percent of the porous fibers.

5. The material of claim 1 , wherein the bioactive ceramic particles are calcium phosphate particles.

6. The material of claim 5 , wherein the biocompatible polymer binder comprises polylactic-co-glycolic acid or polylactide-co-glycolide.

7. The material of claim 5 , wherein the biocompatible polymer binder comprises polycaprolactone.

8. The material of claim 3 , wherein the porous fibers in the material are spaced apart and run parallel with one another.

9. The material of claim 1 , wherein the at least some portions of the one or more porous fibers run parallel with one another and are in contact along their long axes.

10. The material of claim 1 , wherein the one or more porous fibers include intra fiber pores with diameters in the range from about 1 μm to about 10 μm.

11. The material of claim 1 , wherein the one or more porous fibers each have a diameter greater than 100 μm.

12. The material of claim 11 , wherein the one or more porous fibers each have a diameter of less than 400 μm.

13. The material of claim 3 , wherein the porous fibers are spaced apart and intra-scaffold pores are defined by spaces between the fibers, the intra-scaffold pores having diameters of greater than 200 μm.

14. The material of claim 1 further comprising living cells seeded into the material.

15. The material of claim 14 , wherein the living cells comprise mesenchymal stem cells.

16. The material of claim 1 , characterized in that it can undergo a deformation from an original shape to a deformed shaped under a compressive stress.

17. The material of claim 1 , wherein the biocompatible polymer binder comprises an elastomeric polymer.

18. The material of claim 17 , wherein the biocompatible polymer binder comprises polylactic-co-glycolic acid, polylactide-co-glycolide, or polycaprolactone.

19. The material of claim 18 , wherein the bioactive ceramic particles make up at least 80 weight percent of the porous fibers.

20. The material of claim 1 , wherein the shape of the tissue growth material can undergo a 55% compression when a compressive stress is applied and rebound to its original shape when the compressive stress is removed.

21. The material of claim 1 , wherein the shape of the tissue growth material can undergo a 40% stretch when a tensile stress is applied and rebound to its original shape when the tensile stress is removed.

22. The material of claim 1 , wherein the biocompatible polymer binder comprises a biodegradable polymer.

23. The material of claim 1 , wherein the material consists essentially of the one or more porous fibers, the bioactive ceramic particles, optionally, at least one bioactive factor without heat induced degradation, and, optionally, plasticizers.

24. The material of claim 1 , wherein at least one bioactive factor is incorporated directly into the continuous matrix of the porous tissue growth material without heat induced degradation.

25. The material of claim 24 , wherein the at least one bioactive factor is a protein, peptide, growth factor and gene, pharmaceutical compound, or combination thereof.

26. The material of claim 1 , wherein the one or more porous fibers that are incompressible solid structures have a wet density of at least 1.97 g/cm 3 or a dry density of 1.47 g/cm 3 .

27. A method of growing cells, tissue, or both using the material of claim 1 , the method comprising seeding the material with living cells, and culturing the cell-seeded material in a cell or tissue growth culture medium.

28. A method of promoting in vivo tissue growth on the material of claim 1 , the method comprising implanting the material into a living animal.

29. The method of claim 28 , wherein the animal is a human.

30. The method of claim 28 , wherein the material comprises a plurality of stacked layers, each layer in the plurality of stacked layers comprising one or more of the porous fibers.

31. A solvent-based 3D printed porous tissue growth material comprising at least one layer comprising one or more porous fibers, the one or more porous fibers are a continuous matrix of a biocompatible polymer binder with a microstructure formed from a solvent-based ink extruded at room temperature with the solvent evaporated upon extruding and with intra fiber pores and bioactive ceramic particles dispersed throughout the microstructure, the bioactive ceramic particles make up at least 70 weight percent of the one or more porous fibers, the biocompatible polymer binder makes up from 10 weight percent to 30 weight percent of the combined weight of the bioactive ceramic particles and the biocompatible polymer binder, and one or more porous fibers are osteogenically active and can undergo a reversible deformation when a compressive or tensile stress is applied and then removed.

32. A solvent-based 3D printed porous tissue growth material comprising at least one layer comprising one or more porous fibers, the one or more porous fibers are formed from a solvent-based ink extruded at room temperature with the solvent evaporated upon extruding to form a microstructure with a continuous matrix of a biocompatible polymer binder with intra fiber pores and bioactive ceramic particles dispersed throughout the microstructure, the bioactive ceramic particles make up at least 70 weight percent of the one or more porous fibers, one or more porous fibers are osteogenically active and can undergo a reversible deformation when a compressive or tensile stress is applied and then removed, and the bioactive ceramic particles are dispersed in the continuous matrix of the biocompatible binder that allows the bioactive ceramic particles to translate upon mechanical loading and return to their original position upon unloading.

33. A solvent-based 3D printed porous tissue growth material comprising at least one layer comprising one or more porous fibers with a microstructure formed from a solvent-based ink extruded at room temperature with the solvent evaporated upon extruding, the one or more porous fibers have a diameter greater than 100 μm and a continuous matrix of a biocompatible polymer binder with intra fiber pores and bioactive ceramic particles dispersed throughout the microstructure, the bioactive ceramic particles make up at least 70 weight percent of the one or more porous fibers, and the one or more porous fibers are osteogenically active and can undergo a reversible deformation when a compressive or tensile stress is applied and then removed.

Assignments (1)
NUNC PRO TUNC ASSIGNMENT Recorded Mar 22, 2021
From: SHAH, RAMILLE N.; JAKUS, ADAM E.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 055672/0409 →
Continuity (4)
Continuation 14450220 · Aug 2, 2014
Provisional Application 61993360 · May 15, 2014
Provisional Application 61861545 · Aug 2, 2013
Related Publication 20180243484A1 · Aug 30, 2018
Cited By (1)
US 12,734,278